Page last updated: 2024-10-19

niacinamide and Thyroid Diseases

niacinamide has been researched along with Thyroid Diseases in 4 studies

nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.

Thyroid Diseases: Pathological processes involving the THYROID GLAND.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Skrypko, V1
Pasko, A1
Churpiy, I1
Kovalenko, A1
Zaplutanov, V1
Golub, IE1
Pinskiĭ, SB1
Sorokina, LV1
Ivankova, EN1
Kovalenko, AL1
Daimon, M1
Kato, T2
Kaino, W1
Takase, K1
Karasawa, S1
Wada, K1
Kameda, W1
Susa, S1
Oizumi, T1
Tomita, Y1
Zygulska, AL1
Krzemieniecki, K1
Sowa-Staszczak, A1

Reviews

1 review available for niacinamide and Thyroid Diseases

ArticleYear
Hypothyroidism during treatment with tyrosine kinase inhibitors.
    Endokrynologia Polska, 2012, Volume: 63, Issue:4

    Topics: Carcinoma, Renal Cell; Dose-Response Relationship, Drug; Gastrointestinal Neoplasms; Humans; Indoles

2012

Other Studies

3 other studies available for niacinamide and Thyroid Diseases

ArticleYear
SURGICAL PREVENTION AND TREATMENT OF POSTOPERATIVE HYPOPARATHYROIDISM IN PATIENTS OPERATED ON THYROID GLAND.
    Georgian medical news, 2018, Issue:276

    Topics: Antioxidants; Drug Combinations; Flavin Mononucleotide; Humans; Hypoparathyroidism; Hypoxia; Inosine

2018
[Prevention of cognitive dysfunction in patients operated on thyroid gland].
    Khirurgiia, 2011, Issue:10

    Topics: Adolescent; Adult; Aged; Antioxidants; Cognition Disorders; Drug Combinations; Drug Monitoring; Fema

2011
Thyroid dysfunction in patients treated with tyrosine kinase inhibitors, sunitinib, sorafenib and axitinib, for metastatic renal cell carcinoma.
    Japanese journal of clinical oncology, 2012, Volume: 42, Issue:8

    Topics: Adult; Aged; Antineoplastic Agents; Axitinib; Benzenesulfonates; Carcinoma, Renal Cell; Female; Huma

2012